Additionally, although the numbers of tumor-infiltrating NK cells (TINKs) is less than T cells and B cells, cancer patients with higher baseline numbers of TINK cells generally have more favorable outcomes and respond better to anti-PD-(L)1 immunotherapy [259,260]. Here, CD274 is linked to cancer.